PT-141 dosage for men typically ranges from 1.25 mg to 2 mg subcutaneously, with 1.75 mg being the most studied. Learn timing, side effects, and safety.
For most men using PT-141 off-label, the standard dose is 1.75 mg injected subcutaneously, taken about 45 minutes before sexual activity. That number comes from the FDA-approved Vyleesi dose for premenopausal women, and it is also the dose most often studied in men. PT-141 is not FDA-approved for men, so any male use is off-label and should be discussed with a healthcare professional.
What PT-141 Is and How It Works
PT-141, also called bremelanotide, is a synthetic analog of alpha-melanocyte-stimulating hormone. It activates melanocortin receptors in the brain, especially MC4R, which are involved in sexual desire and arousal.
That mechanism makes it different from PDE5 inhibitors like sildenafil and tadalafil. PT-141 acts on the central nervous system rather than on blood flow inside the penis. Some clinicians add it when erectile problems have a desire or neurological component.
PT-141 Dosage for Men: Typical Ranges
No regulatory agency has set a male dose. The table below summarizes ranges reported in clinical trials, published case reports, and common off-label practice.
| Dose | Route | Typical Use | Notes |
|---|---|---|---|
| 1.25 mg | Subcutaneous | Starting dose in some trials | Lower nausea risk, weaker response for some men |
| 1.75 mg | Subcutaneous | Most common off-label dose | Matches the FDA-approved Vyleesi dose |
| 2 mg | Subcutaneous | Higher end of male trial doses | More side effects, not clearly more effective |
| 10 mg | Intranasal (historical) | Older male trials | Intranasal form is no longer marketed |
Most men start at 1.75 mg and adjust only after reviewing side effects with a clinician. Doses above 2 mg have not been shown to work better in controlled studies. The maximum recommended frequency is one dose every 24 hours and no more than eight doses per month.
Should You Start at a Lower Dose?
Some clinicians begin men at 1.25 mg to test tolerability. If nausea is manageable and the response is modest, the dose can move up to 1.75 mg at a later session. Never stack doses on the same day to chase a stronger effect.
Timing, Onset, and Duration
PT-141 is not a daily drug. It is taken as needed, roughly 45 minutes before you want the effect to begin. Onset usually happens within 30 to 60 minutes, and effects can last two to six hours.
Food does not meaningfully change absorption for the subcutaneous form. Injecting into the abdomen or thigh is standard, and rotating sites reduces local irritation.
Nausea is the most common reason men stop using PT-141. Taking the dose on a relatively empty stomach may reduce that side effect for some people.
Injection vs. Other Routes
Only the subcutaneous injection is currently marketed. Older intranasal formulations were studied in men but were discontinued because of inconsistent absorption and nasal irritation.
| Route | Bioavailability | Common Dose | Practical Notes |
|---|---|---|---|
| Subcutaneous injection | High | 1.75 mg | Standard route; requires reconstitution if lyophilized |
| Intranasal | Variable | 10 mg | No longer marketed |
| Sublingual or oral | Very low | Not established | Poor absorption; not recommended |
If you are handling lyophilized research peptide, you will need to reconstitute it before use. Many researchers compare options when choosing the best bac water for peptides, because diluent quality affects stability and dosing accuracy.
How PT-141 Compares to Other Options
Men looking for help with sexual function usually have several choices. Each works differently, and each carries its own approval status.
| Option | How It Works | Typical Dose | FDA-Approved for Men? |
|---|---|---|---|
| PT-141 (bremelanotide) | Central melanocortin agonist | 1.75 mg subcutaneous | No |
| Sildenafil | PDE5 inhibitor | 50 mg oral | Yes |
| Tadalafil | PDE5 inhibitor | 5-20 mg oral | Yes |
| Testosterone therapy | Hormone replacement | Varies by formulation | Yes, for diagnosed deficiency |
Side Effects and Safety Considerations
Common side effects include nausea, flushing, headache, and injection site reactions. These are usually mild and short-lived. Less common but more serious effects include a temporary rise in blood pressure and skin darkening with repeated use.
PT-141 should not be used by men with uncontrolled hypertension or a history of cardiovascular disease. It can also cause a small, short-term drop in heart rate after dosing. Anyone taking blood pressure medication should speak with a physician first.
Because PT-141 is not approved for men, product quality varies widely. Items listed as pt 141 for sale are often marketed as research chemicals and are not tested for human use, which raises the risk of contamination, inaccurate dosing, and unknown reactions.
Other peptides carry similar regulatory warnings. Even compounds with more safety data, such as those covered in bpc-157 dosage for gut health, are not FDA-approved for human use in the United States.
Legal and Research Context
Bremelanotide is a prescription drug in the US, but only for premenopausal women with hypoactive sexual desire disorder. Men cannot get a standard prescription for sexual dysfunction, though some clinicians prescribe it off-label on a case-by-case basis.
Research peptides are a separate category. They are sold for laboratory study, not for human consumption. If you are comparing research compounds, you may also come across epitalon dosage injection protocols or aod-9604 5mg dosage guides, and those products carry the same legal and safety caveats.
Talk to a healthcare professional before using PT-141. A clinician can screen for cardiovascular risk, review your current medications, and help you decide whether off-label use makes sense for your situation.
Frequently Asked Questions
What is the best PT-141 dosage for men?
The most commonly used off-label dose for men is 1.75 mg injected subcutaneously, which matches the FDA-approved Vyleesi dose. Clinical trials in men have tested 1.25 mg and 2 mg, but doses above 2 mg have not been shown to work better. Most clinicians start low and adjust based on tolerability.
How long does PT-141 last in men?
PT-141 usually starts working within 30 to 60 minutes after a subcutaneous injection. Effects typically last two to six hours, though this varies by person. It is taken as needed, not daily, and no more than once every 24 hours.
Is PT-141 FDA-approved for men?
No. Bremelanotide is FDA-approved only for premenopausal women with hypoactive sexual desire disorder. Any male use is off-label, and research peptides sold online are not approved for human consumption at all. Men should consult a healthcare professional before using it.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.